PlainIndex

ETF comparison

IXUS vs PXH

International Total vs International Emerging.

iShares Core MSCI Total International Stock ETF · Invesco RAFI Emerging Markets ETF

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of IXUS and PXH would leave roughly 0.0% of each dollar exposed to the same underlying securities.

IXUS only 0.0% Shared 0.0% PXH only 0.0%
In IXUS only
0 positions
Shared
0 positions
In PXH only
0 positions

Holdings data for IXUS covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for PXH covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

IXUS

iShares Core MSCI Total International Stock ETF

iShares · International Total

90 composite / 100
Expense ratio
0.070%
Net assets
$56.23B
TTM yield
2.94%
Top-10 conc.
—
PXH

Invesco RAFI Emerging Markets ETF

Invesco · International Emerging

61 composite / 100
Expense ratio
0.47%
Net assets
$1.95B
TTM yield
3.56%
Top-10 conc.
—

Sub-score comparison

93
Cost
53
72
Tax efficiency
67
100
Liquidity
69
N/A
Concentration
N/A
—
Tracking quality
—
IXUS sub-score PXH

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

IXUS is 40 bps cheaper than PXH. On a $100,000 position that's about $400/yr more in fees for PXH.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in IXUS

0 total

Every IXUS position is also held by PXH.

Only in PXH

0 total

Every PXH position is also held by IXUS.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.